Does molecular biology play any role in ductal carcinoma in situ?

被引：0

作者：

Sakr, R. A. ^{[1
]}

机构：

[1] Univ Paris 06, Hop Tenon, Gynecol Serv, UMRS938, F-75020 Paris, France

来源：

GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2013年 / 41卷 / 01期

关键词：

Ductal carcinoma in situ; Biomarker; INVASIVE BREAST-CANCER; SURGICAL ADJUVANT BREAST; LYMPH-NODE BIOPSY; HORMONE-RECEPTOR STATUS; LOCAL RECURRENCE; RISK-FACTORS; CYCLIN D1; PROGNOSTIC-SIGNIFICANCE; INTRADUCTAL-CARCINOMA; CONSERVING SURGERY;

D O I：

10.1016/j.gyobfe.2012.11.004

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The natural history of ductal carcinoma in situ (DCIS) is not fully elucidated, but it is recognized that DCIS is the true precursor of invasive carcinoma. Studies could show that DCIS is as heterogeneous as invasive ductal carcinoma, yet, they were unable to predict which DCIS will progress to invasion. Several biomarkers were also demonstrated to have a certain prognostic value. However, except for estrogen receptors and HER2, biomarkers are not yet widely used in clinical practice since their predictive value has not proven to be better than the grade and the classical classifying systems of DCIS. Identifying biomarkers for risk of invasiveness in DOS could be of great value to help high risk patients through the management of their disease and to avoid overtreatment in low risk patients. (C) 2012 Elsevier Masson SAS. All rights reserved.

引用

页码：45 / 53

页数：9

共 50 条

[1] Biology and treatment of ductal carcinoma in situ
Irvine, Tracey
Fentiman, Ian S.
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (02) : 135 - 145
[2] Ductal Carcinoma In Situ: A Rose by Any Other Name
Wickerham, D. Lawrence
Julian, Thomas B.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (20): : 1521 - 1522
[3] The Biology and Management of Ductal Carcinoma in Situ of the Breast
Jatoi, Ismail
Shaaban, Abeer M.
Jou, Eric
Benson, John R.
CURRENT PROBLEMS IN SURGERY, 2023, 60 (08)
[4] Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
Gorringe, Kylie L.
Fox, Stephen B.
FRONTIERS IN ONCOLOGY, 2017, 7
[5] Phenotypic indicators of ductal carcinoma in situ biology
Webster, Lucy R.
Salisbury, Elizabeth L.
Clarke, Christine L.
Balleine, Rosemary L.
CANCER RESEARCH, 2006, 66 (08)
[6] Ductal carcinoma in situ: Is there a role for MRI?
Zuiani, C
Francescutti, GE
Londero, V
Zunnui, I
Bazzocchi, M
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (03) : 89 - 95
[7] Ductal carcinoma in situ: Role of the boost
Azria, D.
Auvray, H.
Barillot, I.
Baumann, P.
Benyoucef, A.
Bons-Rosset, F.
Bontemps, P.
Bourgier, C.
Breton-Callu, C.
Cowen, D.
Cretin, J.
Delalande, B.
Denis, F.
Ellis, S.
Gaci, Z.
Hannoun-Levy, J. -M.
Hasbini, A.
Hennequin, C.
Lagrange, J. -L.
Lartigau, E.
Latorzeff, I.
Le Blanc-Onfroy, M.
Lecouillard, I.
Lemanski, C.
Levy, C.
Maingon, P.
Marchal, C.
Monnier, A.
Pradier, O.
Racadot, S.
Romestaing, P.
Serin, D.
Simon, J. -M.
Teyssier, E.
Tallet, A.
Toledano, A.
Belkaemi, Y.
CANCER RADIOTHERAPIE, 2008, 12 (6-7): : 571 - 576
[8] Ductal carcinoma in situ: Biology, diagnosis, and new therapies
Valenzuela, Marcia
Julian, Thomas B.
CLINICAL BREAST CANCER, 2007, 7 (09) : 676 - 681
[9] Role of sentinel lymph node biopsy in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion
Hoover, SJ
Leitch, AM
Euhus, DM
Peters, GN
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) : S63 - S63
[10] Molecular Grading of Ductal Carcinoma In situ of the Breast
Balleine, Rosemary L.
Webster, Lucy R.
Davis, Sean
Salisbury, Elizabeth L.
Palazzo, Juan P.
Schwartz, Gordon F.
Cornfield, Dennis B.
Walker, Robert L.
Byth, Karen
Clarke, Christine L.
Meltzer, Paul S.
CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8244 - 8252

← 1 2 3 4 5 →